在意识障碍中PET成像和功能性MRI的诊断精度:一项临床验证研究
Johan Stender1, Olivia Gosseries2, Marie-Aurélie Bruno2
1Coma Science Group, Cyclotron Research Center and Neurology Department, University and University Hospital of Liège, Liège, Belgium; Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Lancet (London, England)
|April 22, 2014
概括
大脑 (18) F-氧葡萄糖 (FDG) PET成像准确识别最小意识状态,并预测有意识障碍的患者的康复. 与功能性MRI (fMRI) 相比,这种神经成像技术提供了更好的诊断准确性.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 神经学 神经学
背景情况:
- 临床床检查在准确诊断不响应性清醒综合征 (UWS) 和最小意识状态 (MCS) 中存在局限性.
- 对于这些疾病,在临床环境中使用PET和fMRI等神经成像技术的诊断和预后价值还没有完全确定.
- 这项研究旨在验证两种神经成像方法,PET和fMRI,用于诊断意识障碍.
研究的目的:
- 为了验证大脑 (18)F-氧葡萄糖 (FDG) PET和功能性MRI (fMRI) 用于诊断意识障碍.
- 评估这些神经成像方法的诊断准确性和预后效用.
- 为了比较PET和fMRI在识别最小意识状态和预测患者结果方面的有效性.
主要方法:
- 一项验证研究,涉及在大学医院诊断出UWS,锁定综合症或MCS的患者.
- 使用昏迷恢复量表修订 (CRS-R) 进行了重复的标准化临床评估.
- 在精神激活任务中使用大脑 (18) F-FDG PET 和fMRI,CRS-R诊断作为参考标准.
主要成果:
- (18) F-FDG PET在识别MCS方面表现出高灵敏度 (93%) 和高一致性 (85%) 与CRS-R得分.
- 活跃的fMRI显示MCS诊断的敏感性较低 (45%),与PET相比,与行为评分的一致性较低 (63%).
- (18)F-FDG PET在74%的患者中正确预测了结果,而fMRI在56%的患者中预测了结果.
结论:
- 大脑 (18) F-FDG PET是补充病床检查的宝贵工具,用于诊断UWS并预测长期康复.
- 活性fMRI也可能有助于差异诊断,但似乎不如PET准确.
- 神经成像,特别是PET,可以识别行为不响应的患者的意识,其中很大一部分随后恢复了意识.
相关概念视频
Brain Imaging
1.0K
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
1.0K
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)

